Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 19 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2019Higher serum sex hormone-binding globulin levels are associated with incident cardiovascular disease in menGyawali, P.; Martin, S.A.; Heilbronn, L.K.; Vincent, A.D.; Jenkins, A.J.; Januszewski, A.S.; Adams, R.J.T.; O'Loughlin, P.D.; Wittert, G.A.
2021Diet quality trajectories and cardiovascular phenotypes/metabolic syndrome risk by 11-12 yearsKerr, J.A.; Liu, R.S.; Gasser, C.E.; Mensah, F.K.; Burgner, D.; Lycett, K.; Gillespie, A.N.; Juonala, M.; Clifford, S.A.; Olds, T.; Saffery, R.; Gold, L.; Liu, M.; Azzopardi, P.; Edwards, B.; Dwyer, T.; Wake, M.
2019Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trialByrnes, J.; Ball, J.; Gao, L.; Kai Chan, Y.; Kularatna, S.; Stewart, S.; Scuffham, P.A.
2018Improving the cardiometabolic health of people with psychosis: a protocol for a randomised controlled trial of the Physical Health Nurse Consultant serviceHappell, B.; Curtis, J.; Banfield, M.; Goss, J.; Niyonsenga, T.; Watkins, A.; Platania-Phung, C.; Moon, L.; Batterham, P.; Scholz, B.; Prescott, V.; Stanton, R.
2018Patterns and trends of potentially inappropriate high-density lipoprotein cholesterol testing in Australian adults at high risk of cardiovascular disease from 2008 to 2014: analysis of linked individual patient data from the Australian Medicare Benefits Schedule and Pharmaceutical Benefits SchemeHajati, F.; Atlantis, E.; Bell, K.; Girosi, F.
2020Associations between area socioeconomic status, individual mental health, physical activity, diet and change in cardiometabolic risk amongst a cohort of Australian adults: a longitudinal path analysisCarroll, S.J.; Dale, M.J.; Niyonsenga, T.; Taylor, A.W.; Daniel, M.; Suominen, S.
2020Coal-mine fire-related fine particulate matter and medical-service utilization in Australia: a time-series analysis from the Hazelwood Health StudyJohnson, A.L.; Gao, C.X.; Dennekamp, M.; Williamson, G.J.; Carroll, M.T.C.; Dimitriadis, C.; Dipnall, J.F.; Ikin, J.F.; Johnston, F.H.; McFarlane, A.C.; Sim, M.R.; Stub, D.A.; Abramson, M.J.; Guo, Y.
2023Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialGray, M.P.; Berman, Y.; Bottà, G.; Grieve, S.M.; Ho, A.; Hu, J.; Hyun, K.; Ingles, J.; Jennings, G.; Kilov, G.; Levesque, J.F.; Meikle, P.; Redfern, J.; Usherwood, T.; Vernon, S.T.; Nicholls, S.J.; Figtree, G.A.
2021Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trialVenkataraman, P.; Huynh, Q.; Nicholls, S.J.; Stanton, T.; Watts, G.F.; Marwick, T.H.
2023Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)Zoungas, S.; Curtis, A.; Spark, S.; Wolfe, R.; McNeil, J.J.; Beilin, L.; Chong, T.T.J.; Cloud, G.; Hopper, I.; Kost, A.; Nelson, M.; Nicholls, S.J.; Reid, C.M.; Ryan, J.; Tonkin, A.; Ward, S.A.; Wierzbicki, A.